Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,265 across all filing types
Latest filing 2021-05-28 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
We refer to our announcement of March 23, 2016, wherein we had informed about the Distribution Services Agreement entered into between AstraZeneca Pharma India Limited (AstraZeneca India) ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding a change in business relationship and discontinuation of a distribution agreement between AstraZeneca Pharma India Limited and Sun Pharma Laboratories Limited. It details the termination of a distribution services agreement and the initiation of a transition supply agreement. There is no financial data, no mention of financial results, no regulatory filings like audit or annual reports, no voting results, no management changes, no earnings release, no legal proceedings, and no merger or acquisition activity. The document is an announcement of a business relationship change, specifically about distribution agreements, which does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is a regulatory announcement informing the stock exchanges about a material business update. Given the content and the nature of the document, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length is short (2434 characters), and it is not an announcement of a report publication but a direct announcement of a business event. Therefore, the classification is RNS with high confidence.
2021-05-28 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding a change in business relationship and discontinuation of a distribution agreement between AstraZeneca Pharma India Limited and Sun Pharma Laboratories Limited. It details the termination of a distribution services agreement and the initiation of a transition supply agreement. There is no financial data, no mention of financial results, no regulatory filings like audit reports or annual reports, no voting results, no management changes, no merger or acquisition activity, and no earnings information. The document is an announcement of a business relationship change, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2021-05-28 English
We are enclosing herewith Certificate dated May 4, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization regulations for the period 01.04.2021 to 30.04.2021. It is addressed to stock exchanges and the company secretary. The document is short (3252 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance certificate related to share dematerialization and transfer agent activities, fitting best under Regulatory Filings (RNS) as it is a regulatory compliance document that does not fit other specific categories.
2021-05-26 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate issued pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance related to dematerialization of securities for the period 01.04.2021 to 30.04.2021. It is addressed to stock exchanges and signed by the company secretary and the registrar and transfer agent. The document is short (3252 characters) and primarily serves as a compliance certificate rather than a full financial report or detailed filing. It does not contain financial statements, management discussion, or other report content. It is a regulatory compliance certificate, which fits best under Regulatory Filings (RNS) as per the certification rule and fallback category for miscellaneous filings that do not fit other categories.
2021-05-26 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated May 26, 2021, informing stock exchanges about the approval by the Board of Directors to convene the 42nd Annual General Meeting (AGM) scheduled for August 9, 2021. It references the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, indicating a regulatory compliance announcement. The content is about the scheduling and approval of the AGM, not the AGM materials or minutes themselves. The document length is only 1204 characters, which is quite short and does not contain any financial data or detailed report content. Therefore, it is an announcement related to the AGM, not the AGM report or presentation itself. According to the filing definitions, this fits best under AGM Information (AGM-R) as it relates to the AGM event, but since it is only an announcement of the AGM date and approval, it is more precisely a Regulatory Filing (RNS) because it is a regulatory announcement about the AGM scheduling rather than the AGM materials or voting results. However, the filing definitions specify AGM Information (AGM-R) as presentations and materials shared during the AGM, which this is not. It is also not a Report Publication Announcement (RPA) because it does not mention any report being published or attached. Given the nature of the document as a formal notification to stock exchanges about the AGM date and approval, the best classification is Regulatory Filings (RNS).
2021-05-26 English
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at their meeting held on May ....
AGM Information Classification · 95% confidence The document is a short announcement dated May 26, 2021, informing stock exchanges about the approval by the Board of Directors to convene the 42nd Annual General Meeting (AGM) scheduled for August 9, 2021. It references the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, which govern such disclosures. The document does not contain any financial data, detailed reports, or presentations but simply notifies the exchanges of the AGM date and mode (video conferencing). The length is only 1204 characters, indicating it is a brief notice rather than a full report or presentation. According to the rules, such a document is best classified as AGM Information (AGM-R) because it relates to the AGM and is a communication about the meeting itself, not the meeting materials or results.
2021-05-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.